U.S. markets closed

Reliq Health Technologies Inc. (RQHTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.3249+0.0074 (+2.34%)
At close: 1:07PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.3175
Open0.3160
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.3133 - 0.3249
52 Week Range0.0800 - 0.4700
Volume26,600
Avg. Volume34,342
Market Cap52.587M
Beta (5Y Monthly)1.36
PE Ratio (TTM)N/A
EPS (TTM)-0.1150
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Reliq Health Technologies, Inc. Engages Lytham Partners to Lead U.S. Investor Relations Outreach Program
    GlobeNewswire

    Reliq Health Technologies, Inc. Engages Lytham Partners to Lead U.S. Investor Relations Outreach Program

    HAMILTON, Ontario, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing digital health company that develops innovative Virtual Care software as a service (SaaS) solutions for the Community Healthcare market has retained Lytham Partners, LLC ("Lytham Partners") to lead a U.S. investor relations program. For more than 20 years, Lytham Partners has been one of the industry’s leading investor relations firms in the U.S., having created one of the largest and most diverse networks of institutional investors, while creating a framework of best practices in all aspects of corporate and shareholder communications.“We made significant progress in 2020 in the United States by increasing our penetration beyond our historical markets of Florida and South Texas,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “We are now working with clients across the U.S. and have a clear path to cashflow positive in Q1 2021. Given our recent progress and anticipated growth in 2021, we believe that this is an opportune time to increase awareness of our company within the U.S. investment community. We look forward to working with the team at Lytham Partners, which has a strong understanding of the healthcare technology space and a proven track record of helping public companies communicate their story to the largest and most relevant cross section of institutional investors."Ben Shamsian, Vice President of Lytham Partners, said, "Given Reliq’s fast growing and diversified customer base across the United States, we believe the U.S. investment community will be interested to learn more about their unique value proposition and opportunities ahead to create value for shareholders. We look forward to introducing the Company to our platform of investors while keeping shareholders apprised of the developments taking place at the Company."In connection with the engagement, Lytham Partners will be compensated USD $6,000 per month.The Company also announces the granting of stock options under its Stock Option Plan to purchase an aggregate of 500,000 common shares of the Company at an exercise price of $0.415 per share for a five year term. The stock options were granted to the CFO of the Company pursuant to Reliq’s Stock Option Plan and the policies of the TSX Venture Exchange and vest over one year.About Lytham Partners For more than 20 years, Lytham Partners has been one of the country's leading investor relations firms, having created one of the industry's largest and most diverse networks of institutional investors, while creating a framework of best practices in all aspects of corporate and shareholder communications. In addition to their relationships with many of the industry's most respected institutional investors, Lytham Partners has spent the past two decades creating an integrated platform that allows its clients far reaching exposure to investors in a consistent and in-depth format. This platform is matched with a communications and positioning approach that is streamlined throughout press releases, conference calls, investor presentations, corporate profiles, and websites. For more information visit our website at www.lythampartners.com.About Reliq Health Reliq Health Technologies is a rapidly growing digital health company that specializes in developing innovative Virtual Care software as a service (SaaS) solutions for the Community Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTCQB as RQHTF and on the WKN as A2AJTB.ON BEHALF OF THE BOARD “Dr. Lisa Crossley” CEO and DirectorFor further information please contact:Company Contact Investor Relations at ir@reliqhealth.comLytham Partners, LLC Ben Shamsian New York | Phoenix Telephone: 646-829-9701 shamsian@lythampartners.comNeither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.Cautionary Statements Regarding Forward Looking Information Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.Reliq Health Technologies Inc. (the "Company") does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.SOURCE: Reliq Health Technologies Inc.

  • Reliq Health Technologies, Inc. Launches New Annual Wellness Visit Product and Announces New US Contract
    GlobeNewswire

    Reliq Health Technologies, Inc. Launches New Annual Wellness Visit Product and Announces New US Contract

    HAMILTON, Ontario, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, today announced that it has launched a new Annual Wellness Visit Support service and signed a contract with its first client to subscribe to this service. “We’re excited to be launching our new service to help Primary Care Providers complete Annual Wellness Visits (AWV) using our Telemedicine platform and Care Management Center, and to have signed our first contract to provide this service,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “Physicians across the US are facing overwhelming workloads due to COVID, and now flu season. We launched this new service based on demand from our clients, many of whom have been so busy this year that they have only been able to complete 50% of the Annual Wellness Visits they would normally provide. Annual Wellness Visits are a significant revenue stream for our clients, and these regular health checks are critical to ensuring proactive care for their patients. By having our Care Management Center complete the Health Risk Assessment component of the Annual Wellness Visit and using our Telemedicine platform for virtual visits, clinicians can dramatically increase their capacity to provide these vital annual health checks. We are already starting to conduct the Health Risk Assessments and scheduling virtual visits for patients as of this week, and we expect many of our other existing clients to subscribe to this new service in 2021. Reliq‘s revenue per AWV is $70 USD.”About Reliq HealthReliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq’s powerful iUGO Care platform supports care coordination and community-based healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.ON BEHALF OF THE BOARD“Dr. Lisa Crossley”CEO and DirectorFor further information please contact:Investor Relations at ir@reliqhealth.comNeither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.Cautionary Statements Regarding Forward Looking InformationCertain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.Reliq Health Technologies Inc. (the "Company") does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.SOURCE: Reliq Health Technologies Inc.

  • Reliq Health Technologies, Inc. Announces 15 New Clients with over 12,000 New Patients in Central and North Texas and Puerto Rico
    GlobeNewswire

    Reliq Health Technologies, Inc. Announces 15 New Clients with over 12,000 New Patients in Central and North Texas and Puerto Rico

    HAMILTON, Ontario, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, today announced that it is onboarding 15 new clients in Texas and Puerto Rico who will use its proprietary iUGO Care Remote Patient Monitoring (RPM), Chronic Care Management (CCM), Behavioral Health Integration (BHI) and Telemedicine platform. “We are very pleased to have added fifteen new clients to our customer base in Central and North Texas and Puerto Rico,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “These clients have over 12,000 eligible patients who will be using Reliq’s iUGO Care Software and Care Management services, at an average revenue of $65 USD per patient per month. We have already begun onboarding patients for these new clients and expect to complete the onboarding over the next 4 – 6 months. The new clients include physician practices, home health agencies and a Medical Clinic with over 10 locations between Dallas and San Antonio, Texas. Patient onboarding continues to accelerate, despite the holiday season and the worsening global pandemic. The Company remains on track to achieve cashflow positive in Calendar Q1 2021.”About Reliq Health Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq’s powerful iUGO Care platform supports care coordination and community-based healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.ON BEHALF OF THE BOARD “Dr. Lisa Crossley” CEO and DirectorFor further information please contact: Investor Relations at ir@reliqhealth.comNeither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.Cautionary Statements Regarding Forward Looking Information Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.Reliq Health Technologies Inc. (the "Company") does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.SOURCE: Reliq Health Technologies Inc.